Prenatal Management of 746 Pregnancies at Risk for Congenital Toxoplasmosis

New England Journal of Medicine

Volumn 318, Issue 5, 1988, Pages 271-275

  Daffos, Fernand ^a   Forestier, François ^b   Capella Pavlovsky, Martine ^c   Thulliez, Philippe ^c   Aufrant, Christian ^c   Valenti, Daniel ^c   Cox, Wendy L ^c  

^a Hopital Saint Michel   (France)

^b Royal Australian College of Obstetricians and Gynaecologists ^*  (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE; SULFADOXINE;

ADULT; CHORIORETINITIS; COMPLICATION; CONGENITAL DISORDER; DIAGNOSIS; DRUG THERAPY; FEMALE; FETUS; FETUS BLOOD; FETUS DISEASE; HUMAN; MAJOR CLINICAL STUDY; MENINGOENCEPHALITIS; PREGNANCY; PRIORITY JOURNAL; PROTOZOON; TOXOPLASMA GONDII; ULTRASOUND;

EID: 0023845334     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198802043180502     Document Type: Article

References (13)

1. Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M. Prenatal diagnosis of congenital toxoplasmosis. Lancet 1985; 1: 500–4.
2. Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol 1985; 153: 655–60.
3. Forestier F, Daffos F, Rainaut M, Cox WL. The assessment of fetal blood samples. Am J Obstet Gynecol (in press).
4. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 2nd ed. Philadelphia: W.B. Saunders, 1983:143–263.
5. Couvreur J, Nottin N, Desmonts G. La toxoplasmose congénitale traitée: résultats cliniques et biologiques. Ann Pediatr (Paris) 1980; 27: 647–52.
6. Daffos F, Forestier F, Grangeot-Keros L, et al. Prenatal diagnosis of congenital rubella. Lancet 1984; 2: 1–3.
7. Thulliez P, Remington JS, Santoro F, Ovlaque G, Sharma S, Desmonts G. Une nouvelle réaction d'agglutination pour le diagnostic du stade évolutif de la toxoplasmose acquise. Pathol Biol 1986; 34: 173–7.
8. Desmonts G, Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Engl J Med 1974; 290: 1110–6.
9. Forestier F, Daffos F, Rainaut M, Desnottes JF, Gaschard JC. Suivi thérapeutique fœtomaternel de la spiramycine en cours de grossesse. Arch Fr Pediatr 1987; 44: 539–44.
10. Couvreur J, Desmonts G, Aron-Rosa D. Le pronostic oculaire de la toxoplasmose congénitale: rôle du traitement: communication préliminaire. Ann Pediatr (Paris) 1984; 31: 855–8.
11. Desmonts G. Prevention de la toxoplasmose: remarques sur l'expérience poursuivie en France. In: Marois M, ed. Prevention of physical and mental congenital defects. Part B. Epidemiology, early detection and therapy, and environmental factors: proceedings of an international conference of the Institut de la Vie held in Strasbourg, France, October 10–17, 1982. New York: Alan R. Liss, 1985:333–7.
12. Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stem R, Campbell CC. Severe cutaneous reactions among American travellers using pyrimethamine- sulphadoxine (Fansidar®) for malaria prophylaxis. Am J Trop Med Hyg 1986; 35: 451–8.
13. Derouin F, Mazeron MC. Isolement et identification de toxoplasma gondii pour cultures cellulaires: étude de 9 souches. Bull Soc Fr Parasitol 1986; 1: 85–8.